Novavax (NVAX) Receivables - Other (2021 - 2026)
Novavax's Receivables - Other was $4.1 million in Q2 2026, down 22.6% from $5.3 million a year earlier and down 2.4% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Receivables - Other (2021 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Other at Novavax came in at $10.8 million, up 100.0% from FY2024.
- Receivables - Other shows a four-year compound annual growth rate of -25.6% (FY2021 to FY2025).
- In earlier years, Receivables - Other was $5.4 million in FY2024 (-50.0%), $10.8 million in FY2023 (-62.2%), $28.6 million in FY2022 (-19.0%) and $35.3 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Receivables - Other since Q2 2024.
- Compared with a year earlier, Receivables - Other was higher in two of the last seven quarters, with growth averaging 3.2%.
- The best year-over-year quarter for Receivables - Other over five years was Q2 2025 (growth of 130.4%); the worst was Q1 2024 (a decline of 99.5%).
- Per Business Quant data, NVAX's Receivables - Other in the three quarters before Q2 2026 was $4.2 million (Q1 2026), $10.8 million (Q4 2025) and $5.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Novavax | 1.78 Bn | -1.22 Bn | 42.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.10 Mn |
| Mar 31, 2026 | 4.20 Mn |
| Dec 31, 2025 | 10.80 Mn |
| Sep 30, 2025 | 5.20 Mn |
| Jun 30, 2025 | 5.30 Mn |
| Mar 31, 2025 | 6.10 Mn |
| Dec 31, 2024 | 5.40 Mn |
| Sep 30, 2024 | 6.20 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 10.80 Mn |
| Sep 30, 2023 | 52.60 Mn |
| Jun 30, 2023 | 60.50 Mn |
| Mar 31, 2023 | 42.70 Mn |
| Dec 31, 2022 | 28.60 Mn |
| Sep 30, 2022 | 68.00 Mn |
| Jun 30, 2022 | 29.00 Mn |
| Mar 31, 2022 | 52.30 Mn |
| Dec 31, 2021 | 35.30 Mn |
| Sep 30, 2021 | 34.68 Mn |
API Access
Novavax Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();